These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8020567

  • 1. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M, Chevalier S, Lebrun JJ, Kelly P, Pouplard A, Wijdenes J, Gascan H.
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [Abstract] [Full Text] [Related]

  • 2. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I, Horsten U, Pflanz S, Dahmen H, Küster A, Grötzinger J, Heinrich PC, Müller-Newen G.
    J Immunol; 1999 Feb 01; 162(3):1480-7. PubMed ID: 9973404
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J, Heinrich PC, Müller-Newen G, Roche C, Gu ZJ, Clément C, Klein B.
    Eur J Immunol; 1995 Dec 01; 25(12):3474-81. PubMed ID: 8566040
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1996 Jun 21; 271(25):14764-72. PubMed ID: 8662918
    [Abstract] [Full Text] [Related]

  • 5. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.
    Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716
    [Abstract] [Full Text] [Related]

  • 6. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, Fridman WH, Tartour E.
    Clin Cancer Res; 1997 Aug 01; 3(8):1443-51. PubMed ID: 9815830
    [Abstract] [Full Text] [Related]

  • 7. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J, Sun RX, Cotte N, Gaillard JP, Mani JC, Klein B, Brochier J.
    Cytokine; 1997 Apr 01; 9(4):233-41. PubMed ID: 9112331
    [Abstract] [Full Text] [Related]

  • 8. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep 01; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX, Gennaro C, Rocco S, Gu ZJ, Klein B.
    Eur Cytokine Netw; 1997 Mar 01; 8(1):51-6. PubMed ID: 9110148
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 11. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
    Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T, Yang YC.
    J Immunol; 1993 Sep 01; 151(5):2555-61. PubMed ID: 8360477
    [Abstract] [Full Text] [Related]

  • 12. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T, Matsuda T, Nakajima K.
    Stem Cells; 1994 May 01; 12(3):262-77. PubMed ID: 8075593
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-11 and its receptor.
    Yang YC, Yin T.
    Biofactors; 1992 Dec 01; 4(1):15-21. PubMed ID: 1292471
    [Abstract] [Full Text] [Related]

  • 14. Biosynthetic and glycosylation events of the IL-6 receptor beta-subunit, gp130.
    Wang Y, Fuller GM.
    J Cell Biochem; 1995 Apr 01; 57(4):610-8. PubMed ID: 7615645
    [Abstract] [Full Text] [Related]

  • 15. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K.
    Cell Growth Differ; 1996 Jul 01; 7(7):923-9. PubMed ID: 8809410
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 19. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ, Zhang XG, Hallet MM, Lu ZY, Wijdenes J, Rossi JF, Klein B.
    Exp Hematol; 1996 Aug 01; 24(10):1195-200. PubMed ID: 8765494
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.